|
11HK
SARS-CoV-2 spike S2 trimer stabilized in the early fusion intermediate conformation (E-FICs-v3) bound to the VN01H1 Fab (Fab local refinement)
Deposited 2026-02-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 9
PDB declaration: nonameric
|
Chain A
1–94（94 aa）
Chain D
1–94（94 aa）
Chain G
1–94（94 aa）
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.70 Å
|
|
11HL
SARS-CoV-2 spike S2 trimer stabilized in the early fusion intermediate conformation (E-FICs-v3) bound to the VN01H1 Fab (S2 local refinement)
Deposited 2026-02-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer；Protein × 3
PDB declaration: trimeric
|
Chain A
1–94（94 aa）
Chain B
1–94（94 aa）
Chain C
1–94（94 aa）
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.80 Å
|
|
11HN
SARS-CoV-2 spike S2 trimer stabilized in the early fusion intermediate conformation (E-FICs-v3) bound to C77G12 (S2 local refinement)
Deposited 2026-02-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer；Protein × 3
PDB declaration: trimeric
|
Chain A
1–94（94 aa）
Chain B
1–94（94 aa）
Chain C
1–94（94 aa）
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 12
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.70 Å
|
|
11HW
SARS-CoV-2 spike S2 trimer stabilized in the early fusion intermediate conformation (E-FICs-v3) bound to C77G12 (Fab local refinement)
Deposited 2026-02-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 9
PDB declaration: nonameric
|
Chain A
1–94（94 aa）
Chain B
1–94（94 aa）
Chain G
1–94（94 aa）
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 6
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.80 Å
|
|
1EUV
X-RAY STRUCTURE OF THE C-TERMINAL ULP1 PROTEASE DOMAIN IN COMPLEX WITH SMT3, THE YEAST ORTHOLOG OF SUMO.
Deposited 2000-04-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain B
13–98（86 aa）
Fragment：SMT3 RESIDUES 13-98
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；294 K；0.1M MES pH6.5, 10% w/v polyethylene glycol 20000, 3% w/v 1,6-hexandiol, VAPOR DIFFUSION, HANGING DROP, temperature 294K
|
Resolution 1.60 Å
R-free 0.251
|
|
1L2N
Smt3 Solution Structure
Deposited 2002-02-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain A
1–101（101 aa）
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 6.5；293 K；Pressure 1
NMR sample composition
1 mM C13 and 15N Labelled | 90% H2O/10% D2O
|
Resolution not provided
|
|
2EKE
Structure of a SUMO-binding-motif mimic bound to Smt3p-Ubc9p: conservation of a noncovalent Ubiquitin-like protein-E2 complex as a platform for selective interactions within a SUMO pathway
Deposited 2007-03-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain C
13–98（86 aa）
|
Mutation：thrombin site, Ubiquitin-like
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 5.5；277 K；18% PEG 3350, 0.2M magnesium chloride, 0.1M Bis-Tris, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.90 Å
R-free 0.250
|
|
2EKE
Structure of a SUMO-binding-motif mimic bound to Smt3p-Ubc9p: conservation of a noncovalent Ubiquitin-like protein-E2 complex as a platform for selective interactions within a SUMO pathway
Deposited 2007-03-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain D
13–98（86 aa）
|
Mutation：thrombin site, Ubiquitin-like
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 5.5；277 K；18% PEG 3350, 0.2M magnesium chloride, 0.1M Bis-Tris, pH 5.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.90 Å
R-free 0.250
|
|
3PGE
Structure of sumoylated PCNA
Deposited 2010-11-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain A
1–98（98 aa）
Fragment：sumo-C fragment of PCNA
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 5.6；291 K；2.0M Ammonium Sulfate, 0.1M sodium Citrate, pH 5.6, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 2.80 Å
R-free 0.253
|
|
3QHT
Crystal Structure of the Monobody ySMB-1 bound to yeast SUMO
Deposited 2011-01-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain A
2–98（97 aa）
|
Not recorded
|
GOL GLYCEROL × 8
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION；pH 8；292 K；14% PEG8000, 16% glycerol, pH 8.0, VAPOR DIFFUSION, temperature 292K
|
Resolution 2.40 Å
R-free 0.272
|
|
3QHT
Crystal Structure of the Monobody ySMB-1 bound to yeast SUMO
Deposited 2011-01-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain B
2–98（97 aa）
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION；pH 8；292 K；14% PEG8000, 16% glycerol, pH 8.0, VAPOR DIFFUSION, temperature 292K
|
Resolution 2.40 Å
R-free 0.272
|
|
3TIX
Crystal structure of the Chp1-Tas3 complex core
Deposited 2011-08-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain A
3–98（96 aa）
Fragment：N-TERMINAL DOMAIN,N-TERMINAL DOMAIN
|
Not recorded
|
CL CHLORIDE ION × 4
K POTASSIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.2；290 K；microseeding in 0.95 M potassium sodium tartrate, 100 mM MES, 180 mM sodium thiocyanate, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 290K
|
Resolution 2.90 Å
R-free 0.243
|
|
3TIX
Crystal structure of the Chp1-Tas3 complex core
Deposited 2011-08-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain C
3–98（96 aa）
Fragment：N-TERMINAL DOMAIN,N-TERMINAL DOMAIN
|
Not recorded
|
CL CHLORIDE ION × 4
K POTASSIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.2；290 K；microseeding in 0.95 M potassium sodium tartrate, 100 mM MES, 180 mM sodium thiocyanate, pH 6.2, VAPOR DIFFUSION, HANGING DROP, temperature 290K
|
Resolution 2.90 Å
R-free 0.243
|
|
3UF8
Crystal structure of a SMT fusion Peptidyl-prolyl cis-trans isomerase with a G95A surface mutation from Burkholderia pseudomallei complexed with FK506
Deposited 2011-10-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain A
13–98（86 aa）
Fragment：Q12306 residues 13-98, Q3JK38 residues 2-113
|
Mutation：G95A
|
FK5 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7；290 K；Internal tracking number 226425. JCSG well A8. 0.2M Ammonium Formate, 20.0% w/v PEG3500, PEG400 Cryo. BupsA.00130.a.D242 PD00198 21.4mg/ml, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 290K
|
Resolution 1.50 Å
R-free 0.183
|
|
3UQA
Crystal structure of a SMT fusion Peptidyl-prolyl cis-trans isomerase with surface mutation A54E from Burkholderia pseudomallei complexed with FK506
Deposited 2011-11-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain A
13–98（86 aa）
Fragment：Q12306 residues 13-98, Q3JK38 residues 2-113
|
Mutation：A54E
|
FK5 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN × 1
PEG DI(HYDROXYETHYL)ETHER × 1
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7；290 K；Internal tracking number 226422. JCSG well A9. 0.2M Ammonium Chloride, 20.0% w/v PEG3500, 30% PEG400 Cryo. BupsA.00130.a.D220 PD00197 19.3mg/ml., pH 7.00, vapor diffusion, sitting drop, temperature 290K
|
Resolution 1.55 Å
R-free 0.193
|
|
3UQB
Crystal structure of a SMT Fusion PEPTIDYL-PROLYL CIS-TRANS ISOMERASE with surface mutation D44G from Burkholderia pseudomallei complexed with FK506
Deposited 2011-11-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain A
13–98（86 aa）
Fragment：Q12306 residues 13-98, Q3JK38 residues 2-113
|
Mutation：D44G
|
FK5 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 9；290 K；Internal tracking number 226421. PACT well B6. 0.1M MIB Buffer pH 9.0, 25.0% w/v PEG1500, 30% PEG400 Cryo. BUPSA.00130.A.D214 PD00190/6 23.7mg/ml, vapor diffusion, sitting drop, temperature 290K, VAPOR DIFFUSION, SITTING DROP
|
Resolution 1.90 Å
R-free 0.228
|
|
3V60
Structure of S. cerevisiae PCNA conjugated to SUMO on lysine 164
Deposited 2011-12-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer；Protein × 6
PDB declaration: hexameric
|
Chain A
20–98（79 aa）
Fragment：unp resicues 20-98
|
Not recorded
|
SO4 SULFATE ION × 18
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 4.5；291 K；4% PEG 8000, 500 mM LiSO4, pH 4.5, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 2.60 Å
R-free 0.249
|
|
3V61
Structure of S. cerevisiae PCNA conjugated to SUMO on lysine 164
Deposited 2011-12-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain A
20–98（79 aa）
Fragment：unp residues 20-98
|
Not recorded
|
BA BARIUM ION × 13
NEQ N-ETHYLMALEIMIDE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；277 K；21% MPD, 100 mM BaCl2, 100 mM Bis-Tris, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 2.80 Å
R-free 0.254
|
|
3V62
Structure of the S. cerevisiae Srs2 C-terminal domain in complex with PCNA conjugated to SUMO on lysine 164
Deposited 2011-12-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer；Protein × 3
PDB declaration: trimeric
|
Chain A
20–98（79 aa）
Fragment：unp residues 20-98
|
Mutation：GSH from N-tag after thrombin cleavage, K19R
Non-standard monomer：Yes (specific site not provided by mmCIF)
|
NEQ N-ETHYLMALEIMIDE × 2
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7.5；279 K；1.9 M AMMONIUM SULFATE
4% PEG 400
100 mM HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
|
Resolution 2.90 Å
R-free 0.237
|
|
3V62
Structure of the S. cerevisiae Srs2 C-terminal domain in complex with PCNA conjugated to SUMO on lysine 164
Deposited 2011-12-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer；Protein × 3
PDB declaration: trimeric
|
Chain D
20–98（79 aa）
Fragment：unp residues 20-98
|
Mutation：GSH from N-tag after thrombin cleavage, K19R
Non-standard monomer：Yes (specific site not provided by mmCIF)
|
NEQ N-ETHYLMALEIMIDE × 2
SO4 SULFATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7.5；279 K；1.9 M AMMONIUM SULFATE
4% PEG 400
100 mM HEPES, pH 7.5, VAPOR DIFFUSION, HANGING DROP, temperature 279K
|
Resolution 2.90 Å
R-free 0.237
|
|
3VAW
Crystal structure of a smt fusion peptidyl-prolyl cis-trans isomerase with surface mutation v3i from burkholderia pseudomallei complexed with fk506
Deposited 2011-12-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain A
13–99（87 aa）
Fragment：Q12306 RESIDUES 13-99, Q3JK38 RESIDUES 2-113
|
Mutation：V3I,V3I
|
FK5 8-DEETHYL-8-[BUT-3-ENYL]-ASCOMYCIN × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；290 K；Internal tracking number 226593. PACT well H3. 0.2M Sodium Iodide, 0.1M Bis-Tris Propane, pH 8.5, 20.0% w/v PEG3350, 30% PEG400 Cryo. BupsA.00130.a.D24 PD00194 19.6mg/ml., vapor diffusion, sitting drop, temperature 290K
|
Resolution 1.55 Å
R-free 0.194
|
|
4FN2
Crystal structure of a SMT fusion Peptidyl-prolyl cis-trans isomerase with surface mutation D44G from Burkholderia pseudomallei complexed with CJ37
Deposited 2012-06-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain A
13–98（86 aa）
Fragment：Q12306 residues 13-98, Q3JK38 residues 2-113
|
Mutation：D44G
|
854 ethyl (2S)-1-(benzylsulfonyl)piperidine-2-carboxylate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 6.5；295 K；Internal tracking number 233926b1. Puck VKT6-6, Morpheus well B1. 10% PEG 20,000, 20% PEG MME550, 0.03M Halides (NaF, NaBr, NaI), 0.1M MES/Imidazole pH 6.5, Direct Cryo. BupsA.00130.a.D214, 20.00 mg/ml, CJ37 (EBSI2854), vapor diffusion, sitting drop, temperature 295K
|
Resolution 1.95 Å
R-free 0.224
|
|
4FN2
Crystal structure of a SMT fusion Peptidyl-prolyl cis-trans isomerase with surface mutation D44G from Burkholderia pseudomallei complexed with CJ37
Deposited 2012-06-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain B
13–98（86 aa）
Fragment：Q12306 residues 13-98, Q3JK38 residues 2-113
|
Mutation：D44G
|
854 ethyl (2S)-1-(benzylsulfonyl)piperidine-2-carboxylate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 6.5；295 K；Internal tracking number 233926b1. Puck VKT6-6, Morpheus well B1. 10% PEG 20,000, 20% PEG MME550, 0.03M Halides (NaF, NaBr, NaI), 0.1M MES/Imidazole pH 6.5, Direct Cryo. BupsA.00130.a.D214, 20.00 mg/ml, CJ37 (EBSI2854), vapor diffusion, sitting drop, temperature 295K
|
Resolution 1.95 Å
R-free 0.224
|
|
4G50
Crystal structure of a SMT fusion Peptidyl-prolyl cis-trans isomerase with surface mutation D44G from Burkholderia pseudomallei complexed with CJ168
Deposited 2012-07-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain A
13–98（86 aa）
Fragment：Q12306 residues 13-98, Q3JK38 residues 2-113
|
Mutation：D44G
|
861 3-(3,4,5-trimethoxyphenyl)propyl (2S)-1-(benzylsulfonyl)piperidine-2-carboxylate × 1
FMT FORMIC ACID × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7.5；295 K；Internal tracking number 233897a9. Puck VKT6-9, JCSG_A8 optimization. 50mM Ammonium formate, 24.55% PEG 3,350, 10% ethylene glycol. BupsA.00130.a.D214, 20.00 mg/ml, CJ168 (EBSI2861), pH 7.5, vapor diffusion, sitting drop, temperature 295K
|
Resolution 1.75 Å
R-free 0.219
|
|
4G50
Crystal structure of a SMT fusion Peptidyl-prolyl cis-trans isomerase with surface mutation D44G from Burkholderia pseudomallei complexed with CJ168
Deposited 2012-07-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain B
13–98（86 aa）
Fragment：Q12306 residues 13-98, Q3JK38 residues 2-113
|
Mutation：D44G
|
861 3-(3,4,5-trimethoxyphenyl)propyl (2S)-1-(benzylsulfonyl)piperidine-2-carboxylate × 1
FMT FORMIC ACID × 2
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7.5；295 K；Internal tracking number 233897a9. Puck VKT6-9, JCSG_A8 optimization. 50mM Ammonium formate, 24.55% PEG 3,350, 10% ethylene glycol. BupsA.00130.a.D214, 20.00 mg/ml, CJ168 (EBSI2861), pH 7.5, vapor diffusion, sitting drop, temperature 295K
|
Resolution 1.75 Å
R-free 0.219
|
|
4GGQ
Crystal structure of a SMT fusion Peptidyl-prolyl cis-trans isomerase from Burkholderia pseudomallei complexed with CJ40
Deposited 2012-08-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain C
13–98（86 aa）
Fragment：Q12306 residues 13-98, Q3JK38 residues 2-113
|
Not recorded
|
CA CALCIUM ION × 1
861 3-(3,4,5-trimethoxyphenyl)propyl (2S)-1-(benzylsulfonyl)piperidine-2-carboxylate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 6.5；295 K；Internal tracking number 235051a1. Puck IBH5-4, Morpheus well A1. 10% PEG 20,000, 20% PEG MME550, 0.03M Divalent Catios (MgCl2, CaCl2), 0.1M MES/Imidazole pH 6.5, Direct Cryo. BupsA.00130.a.D21, 20.00 mg/ml, CJ40 (EBSI2855), vapor diffusion, sitting drop, temperature 295K
|
Resolution 1.95 Å
R-free 0.220
|
|
4GGQ
Crystal structure of a SMT fusion Peptidyl-prolyl cis-trans isomerase from Burkholderia pseudomallei complexed with CJ40
Deposited 2012-08-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain A
13–98（86 aa）
Fragment：Q12306 residues 13-98, Q3JK38 residues 2-113
|
Not recorded
|
CA CALCIUM ION × 1
861 3-(3,4,5-trimethoxyphenyl)propyl (2S)-1-(benzylsulfonyl)piperidine-2-carboxylate × 1
PEG DI(HYDROXYETHYL)ETHER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 6.5；295 K；Internal tracking number 235051a1. Puck IBH5-4, Morpheus well A1. 10% PEG 20,000, 20% PEG MME550, 0.03M Divalent Catios (MgCl2, CaCl2), 0.1M MES/Imidazole pH 6.5, Direct Cryo. BupsA.00130.a.D21, 20.00 mg/ml, CJ40 (EBSI2855), vapor diffusion, sitting drop, temperature 295K
|
Resolution 1.95 Å
R-free 0.220
|
|
4GGQ
Crystal structure of a SMT fusion Peptidyl-prolyl cis-trans isomerase from Burkholderia pseudomallei complexed with CJ40
Deposited 2012-08-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain B
13–98（86 aa）
Fragment：Q12306 residues 13-98, Q3JK38 residues 2-113
|
Not recorded
|
861 3-(3,4,5-trimethoxyphenyl)propyl (2S)-1-(benzylsulfonyl)piperidine-2-carboxylate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 6.5；295 K；Internal tracking number 235051a1. Puck IBH5-4, Morpheus well A1. 10% PEG 20,000, 20% PEG MME550, 0.03M Divalent Catios (MgCl2, CaCl2), 0.1M MES/Imidazole pH 6.5, Direct Cryo. BupsA.00130.a.D21, 20.00 mg/ml, CJ40 (EBSI2855), vapor diffusion, sitting drop, temperature 295K
|
Resolution 1.95 Å
R-free 0.220
|
|
4GGQ
Crystal structure of a SMT fusion Peptidyl-prolyl cis-trans isomerase from Burkholderia pseudomallei complexed with CJ40
Deposited 2012-08-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain D
13–98（86 aa）
Fragment：Q12306 residues 13-98, Q3JK38 residues 2-113
|
Not recorded
|
861 3-(3,4,5-trimethoxyphenyl)propyl (2S)-1-(benzylsulfonyl)piperidine-2-carboxylate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 6.5；295 K；Internal tracking number 235051a1. Puck IBH5-4, Morpheus well A1. 10% PEG 20,000, 20% PEG MME550, 0.03M Divalent Catios (MgCl2, CaCl2), 0.1M MES/Imidazole pH 6.5, Direct Cryo. BupsA.00130.a.D21, 20.00 mg/ml, CJ40 (EBSI2855), vapor diffusion, sitting drop, temperature 295K
|
Resolution 1.95 Å
R-free 0.220
|
|
4GIV
Crystal structure of a SMT fusion Peptidyl-prolyl cis-trans isomerase with surface mutation D44G from Burkholderia pseudomallei complexed with CJ183
Deposited 2012-08-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain A
13–98（86 aa）
Fragment：Q12306 residues 13-98, Q3JK38 residues 2-113
|
Mutation：D44G
|
4GI 3-(pyridin-3-yl)propyl (2S)-1-[(3-nitrophenyl)sulfonyl]piperidine-2-carboxylate × 1
FMT FORMIC ACID × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7.5；295 K；Internal tracking number 232625a12. Puck IBH5-9, JCSG_A8 optimization screen. 50mM Ammonium Formate, 30% PEG3,350, 25% ethylene glycol cryo-protected. BupsA.00130.a.D214, 20.00 mg/ml, CJ183 (EBSI2864), pH 7.5, vapor diffusion, sitting drop, temperature 295K
|
Resolution 2.45 Å
R-free 0.262
|
|
4GIV
Crystal structure of a SMT fusion Peptidyl-prolyl cis-trans isomerase with surface mutation D44G from Burkholderia pseudomallei complexed with CJ183
Deposited 2012-08-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain B
13–98（86 aa）
Fragment：Q12306 residues 13-98, Q3JK38 residues 2-113
|
Mutation：D44G
|
4GI 3-(pyridin-3-yl)propyl (2S)-1-[(3-nitrophenyl)sulfonyl]piperidine-2-carboxylate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7.5；295 K；Internal tracking number 232625a12. Puck IBH5-9, JCSG_A8 optimization screen. 50mM Ammonium Formate, 30% PEG3,350, 25% ethylene glycol cryo-protected. BupsA.00130.a.D214, 20.00 mg/ml, CJ183 (EBSI2864), pH 7.5, vapor diffusion, sitting drop, temperature 295K
|
Resolution 2.45 Å
R-free 0.262
|
|
5D6J
Crystal structure of a mycobacterial protein
Deposited 2015-08-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain B
21–94（74 aa）
Fragment：UNP RESIDUES 21-94
|
Not recorded
|
MG MAGNESIUM ION × 1
ATP ADENOSINE-5'-TRIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
EVAPORATION；281 K；0.2 M sodium malonate, 20% PEG 3350
|
Resolution 2.25 Å
R-free 0.206
|
|
5JNE
E2-SUMO-Siz1 E3-SUMO-PCNA complex
Deposited 2016-04-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 4
PDB declaration: tetrameric
|
Chain A
20–98（79 aa）
Fragment：unp residues 167-445
Chain C
19–98（80 aa）
|
Mutation：Siz1 C361D, Smt3 Delta N-terminus 1-18
Mutation：N-terminal 1-18 delete, K19R
|
ZN ZINC ION × 1
GOL GLYCEROL × 6
6LN ethane-1,2-dithiol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 8.5；291 K；0.1 M Tris-HCl (pH 8.5), 5% PEG 10,000, 0.2 M NaCl, 10% glycerol, 3% dioxane
|
Resolution 2.85 Å
R-free 0.250
|
|
5JNE
E2-SUMO-Siz1 E3-SUMO-PCNA complex
Deposited 2016-04-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer；Protein × 4
PDB declaration: tetrameric
|
Chain E
20–98（79 aa）
Fragment：unp residues 167-445
Chain G
19–98（80 aa）
|
Mutation：Siz1 C361D, Smt3 Delta N-terminus 1-18
Mutation：N-terminal 1-18 delete, K19R
|
ZN ZINC ION × 1
GOL GLYCEROL × 4
6LN ethane-1,2-dithiol × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 8.5；291 K；0.1 M Tris-HCl (pH 8.5), 5% PEG 10,000, 0.2 M NaCl, 10% glycerol, 3% dioxane
|
Resolution 2.85 Å
R-free 0.250
|
|
5KLX
Crystal Structure of SMT Fusion Peptidyl-Prolyl Cis-Trans Isomerase from Burkholderia Pseudomallei Complexed with SF110
Deposited 2016-06-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain A
13–98（86 aa）
Fragment：UNP Q12306 residues 13-98,UNP Q3JK38 residues 2-113
|
Not recorded
|
6UO 2-[(2~{S})-1-(phenylmethyl)sulfonylpiperidin-2-yl]carbonyloxyethyl pyridine-3-carboxylate × 1
MG MAGNESIUM ION × 1
IMD IMIDAZOLE × 1
PEG DI(HYDROXYETHYL)ETHER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 6.5；289 K；BUPSA.00130.A.D21 (CID4597, SMT TAG ON, BATCH 1264062) AT 10.37MG/ML (IN 25MM TRIS, PH8.0, 200MM NACL, 1% GLYCEROL, 1MM TCEP BUFFER) WAS INCUBATED WITH 2MM SF110_S (BSI5665). CRYSTALS WERE PRODUCED BY SITTING DROP VAPOR IFFUSION WITH AN EQUAL VOLUME COMBINATION OF THE PROTEIN/LIGAND COMPLEX AND A SOLUTION CONTAINING 10% W/V PEG20,000, 20% V/V PEG MME 550, 0.03M MGCL2, 0.03M CACL2, 0.1M MES/IMIDAZOLE, PH6.5 (MORPHEUS A1). CRYSTAL TRACKING ID 273103A1, RVA0-10, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K
|
Resolution 2.45 Å
R-free 0.256
|
|
5KLX
Crystal Structure of SMT Fusion Peptidyl-Prolyl Cis-Trans Isomerase from Burkholderia Pseudomallei Complexed with SF110
Deposited 2016-06-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain B
13–98（86 aa）
Fragment：UNP Q12306 residues 13-98,UNP Q3JK38 residues 2-113
|
Not recorded
|
6UO 2-[(2~{S})-1-(phenylmethyl)sulfonylpiperidin-2-yl]carbonyloxyethyl pyridine-3-carboxylate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 6.5；289 K；BUPSA.00130.A.D21 (CID4597, SMT TAG ON, BATCH 1264062) AT 10.37MG/ML (IN 25MM TRIS, PH8.0, 200MM NACL, 1% GLYCEROL, 1MM TCEP BUFFER) WAS INCUBATED WITH 2MM SF110_S (BSI5665). CRYSTALS WERE PRODUCED BY SITTING DROP VAPOR IFFUSION WITH AN EQUAL VOLUME COMBINATION OF THE PROTEIN/LIGAND COMPLEX AND A SOLUTION CONTAINING 10% W/V PEG20,000, 20% V/V PEG MME 550, 0.03M MGCL2, 0.03M CACL2, 0.1M MES/IMIDAZOLE, PH6.5 (MORPHEUS A1). CRYSTAL TRACKING ID 273103A1, RVA0-10, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K
|
Resolution 2.45 Å
R-free 0.256
|
|
5KLX
Crystal Structure of SMT Fusion Peptidyl-Prolyl Cis-Trans Isomerase from Burkholderia Pseudomallei Complexed with SF110
Deposited 2016-06-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain C
13–98（86 aa）
Fragment：UNP Q12306 residues 13-98,UNP Q3JK38 residues 2-113
|
Not recorded
|
6UO 2-[(2~{S})-1-(phenylmethyl)sulfonylpiperidin-2-yl]carbonyloxyethyl pyridine-3-carboxylate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 6.5；289 K；BUPSA.00130.A.D21 (CID4597, SMT TAG ON, BATCH 1264062) AT 10.37MG/ML (IN 25MM TRIS, PH8.0, 200MM NACL, 1% GLYCEROL, 1MM TCEP BUFFER) WAS INCUBATED WITH 2MM SF110_S (BSI5665). CRYSTALS WERE PRODUCED BY SITTING DROP VAPOR IFFUSION WITH AN EQUAL VOLUME COMBINATION OF THE PROTEIN/LIGAND COMPLEX AND A SOLUTION CONTAINING 10% W/V PEG20,000, 20% V/V PEG MME 550, 0.03M MGCL2, 0.03M CACL2, 0.1M MES/IMIDAZOLE, PH6.5 (MORPHEUS A1). CRYSTAL TRACKING ID 273103A1, RVA0-10, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K
|
Resolution 2.45 Å
R-free 0.256
|
|
5KLX
Crystal Structure of SMT Fusion Peptidyl-Prolyl Cis-Trans Isomerase from Burkholderia Pseudomallei Complexed with SF110
Deposited 2016-06-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain D
13–98（86 aa）
Fragment：UNP Q12306 residues 13-98,UNP Q3JK38 residues 2-113
|
Not recorded
|
6UO 2-[(2~{S})-1-(phenylmethyl)sulfonylpiperidin-2-yl]carbonyloxyethyl pyridine-3-carboxylate × 1
MG MAGNESIUM ION × 1
IMD IMIDAZOLE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 6.5；289 K；BUPSA.00130.A.D21 (CID4597, SMT TAG ON, BATCH 1264062) AT 10.37MG/ML (IN 25MM TRIS, PH8.0, 200MM NACL, 1% GLYCEROL, 1MM TCEP BUFFER) WAS INCUBATED WITH 2MM SF110_S (BSI5665). CRYSTALS WERE PRODUCED BY SITTING DROP VAPOR IFFUSION WITH AN EQUAL VOLUME COMBINATION OF THE PROTEIN/LIGAND COMPLEX AND A SOLUTION CONTAINING 10% W/V PEG20,000, 20% V/V PEG MME 550, 0.03M MGCL2, 0.03M CACL2, 0.1M MES/IMIDAZOLE, PH6.5 (MORPHEUS A1). CRYSTAL TRACKING ID 273103A1, RVA0-10, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 289K
|
Resolution 2.45 Å
R-free 0.256
|
|
5V8T
Crystal structure of SMT fusion Peptidyl-prolyl cis-trans isomerase from Burkholderia pseudomallei complexed with SF354
Deposited 2017-03-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain A
13–97（85 aa）
Fragment：unp residues 13-97; unp residues 2-113
|
Not recorded
|
8ZV 2-{[3,5-bis(2-methoxyethoxy)benzene-1-carbonyl]amino}ethyl (2S)-1-(benzylsulfonyl)piperidine-2-carboxylate × 1
FMT FORMIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8；289 K；BupsA.00130.a.D21 (CID4597, SMT tag on, Batch 776103) at 10.37mg/ml (in 25mM Tris, pH8.0, 200mM NaCl, 1% glycerol, 1mM TCEP buffer) was incubated with 2mM SF354 (BSI5672). Crystals were produced by sitting drop vapor diffusion with an equal volume combination of the protein/ligand complex and a solution containing 24.55% (w/v) PEG-3350, 50 mM ammonium formate (JCSG_A8 opt screen d7) and cryoprotected with 15% ethylene glycol. Crystal Tracking ID 274545d7, uxe3-7
|
Resolution 2.10 Å
R-free 0.221
|
|
5V8T
Crystal structure of SMT fusion Peptidyl-prolyl cis-trans isomerase from Burkholderia pseudomallei complexed with SF354
Deposited 2017-03-22
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain B
13–97（85 aa）
Fragment：unp residues 13-97; unp residues 2-113
|
Not recorded
|
8ZV 2-{[3,5-bis(2-methoxyethoxy)benzene-1-carbonyl]amino}ethyl (2S)-1-(benzylsulfonyl)piperidine-2-carboxylate × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8；289 K；BupsA.00130.a.D21 (CID4597, SMT tag on, Batch 776103) at 10.37mg/ml (in 25mM Tris, pH8.0, 200mM NaCl, 1% glycerol, 1mM TCEP buffer) was incubated with 2mM SF354 (BSI5672). Crystals were produced by sitting drop vapor diffusion with an equal volume combination of the protein/ligand complex and a solution containing 24.55% (w/v) PEG-3350, 50 mM ammonium formate (JCSG_A8 opt screen d7) and cryoprotected with 15% ethylene glycol. Crystal Tracking ID 274545d7, uxe3-7
|
Resolution 2.10 Å
R-free 0.221
|
|
5YC2
Crystal structure of inner membrane protein Bqt4 in complex with telomeric protein Rap1
Deposited 2017-09-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain A
20–92（73 aa）
|
Mutation：Q61E
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7.5；277 K；0.1M HEPES sodium pH 7.5, 10% v/v 2-Propanol, 20% w/v Polyethyleneglycol 4000.
|
Resolution 2.70 Å
R-free 0.249
|
|
5YC2
Crystal structure of inner membrane protein Bqt4 in complex with telomeric protein Rap1
Deposited 2017-09-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain C
20–92（73 aa）
|
Mutation：Q61E
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7.5；277 K；0.1M HEPES sodium pH 7.5, 10% v/v 2-Propanol, 20% w/v Polyethyleneglycol 4000.
|
Resolution 2.70 Å
R-free 0.249
|
|
5YCA
Crystal structure of inner membrane protein Bqt4 in complex with LEM2
Deposited 2017-09-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain A
20–92（73 aa）
|
Mutation：Q61E
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 5.6；289 K；1600 mM Sodium citrate tribasic
|
Resolution 1.57 Å
R-free 0.214
|
|
6CFP
CRYSTAL STRUCTURE OF POLYMERASE ACID PROTEIN (PA) FROM INFLUENZA A VIRUS, WILSON-SMITH/1933 (H1N1) BOUND TO FRAGMENT HIT BSI-70565 1-{1-[4-FLUOROPHENYL)METHYL]-2-METHYL-1H-IMIDAZOL-4-YL}ETHAN-1-ONE
Deposited 2018-02-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain A
13–98（86 aa）
|
Not recorded
|
EZS 1-{1-[(4-fluorophenyl)methyl]-2-methyl-1H-imidazol-4-yl}ethan-1-one × 1
DMS DIMETHYL SULFOXIDE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；289 K；MOLECULAR DIMENSIONS MORPHEUS
SCREEN D10: 10% PEG 8000, 20% ETHYLENE GLYCOL; 20MM OF EACH 1,
6-HEXANEDIOL, 1-BUTANOL, 1,2-PROPANEDIOL, 2-PROPANOL, 1,4-
BUTANEDIOL, 1,3-PROPANEDIOL; 100MM TRIS/BICINE PH 8.5;
INVAA.07057.A.D15. AT 20.0 MG/ML, OVERNIGHT SOAK WITH 7 MM
BSI70565, DIRECT CRYO; tray 297881d10, puck WXU6-7
|
Resolution 2.45 Å
R-free 0.231
|
|
6O49
CRYSTAL STRUCTURE OF SMT FUSION PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FROM BURKHOLDERIA PSEUDOMALLEI COMPLEXED WITH SF339
Deposited 2019-02-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain A
13–98（86 aa）
|
Not recorded
|
LL7 (2~{S})-~{N}-[3-oxidanylidene-3-[(3,4,5-trimethoxyphenyl)amino]propyl]-1-(phenylmethyl)sulfonyl-piperidine-2-carboxamide × 1
CA CALCIUM ION × 1
EDO 1,2-ETHANEDIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 6；289 K；BupsA.00130.a.D21 (CID4597, SMT tag on, Batch 1264062) at 10.37mg/ml (in 25mM Tris, pH8.0, 200mM NaCl, 1% glycerol, 1mM TCEP buffer) was incubated with 2mM SF339_S (BSI5671). Crystals were produced by sitting drop vapor diffusion with an equal volume combination of the protein/ligand complex and a solution containing 100 mM MES pH 6.0, 200 mM Calcium chloride dehydrate, 20% PEG6000 (PACT B11). Crystal Tracking ID 297348b11, izs6-2
|
Resolution 1.85 Å
R-free 0.211
|
|
6O49
CRYSTAL STRUCTURE OF SMT FUSION PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FROM BURKHOLDERIA PSEUDOMALLEI COMPLEXED WITH SF339
Deposited 2019-02-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain B
13–98（86 aa）
|
Not recorded
|
LL7 (2~{S})-~{N}-[3-oxidanylidene-3-[(3,4,5-trimethoxyphenyl)amino]propyl]-1-(phenylmethyl)sulfonyl-piperidine-2-carboxamide × 1
CA CALCIUM ION × 1
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 6；289 K；BupsA.00130.a.D21 (CID4597, SMT tag on, Batch 1264062) at 10.37mg/ml (in 25mM Tris, pH8.0, 200mM NaCl, 1% glycerol, 1mM TCEP buffer) was incubated with 2mM SF339_S (BSI5671). Crystals were produced by sitting drop vapor diffusion with an equal volume combination of the protein/ligand complex and a solution containing 100 mM MES pH 6.0, 200 mM Calcium chloride dehydrate, 20% PEG6000 (PACT B11). Crystal Tracking ID 297348b11, izs6-2
|
Resolution 1.85 Å
R-free 0.211
|
|
6O4A
CRYSTAL STRUCTURE OF SMT FUSION PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FROM BURKHOLDERIA PSEUDOMALLEI COMPLEXED WITH SF355
Deposited 2019-02-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain A
13–98（86 aa）
|
Not recorded
|
CA CALCIUM ION × 1
LLD 2-(pyridin-3-ylcarbonylamino)ethyl (2~{S})-1-(phenylmethyl)sulfonylpiperidine-2-carboxylate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 6.5；289 K；BupsA.00130.a.D21 (CID4597, SMT tag on, Batch 1264062) at 10.37mg/ml (in 25mM Tris, pH8.0, 200mM NaCl, 1% glycerol, 1mM TCEP buffer) was incubated with 2mM SF355 (BSI5667). Crystals were produced by sitting drop vapor diffusion with an equal volume combination of the protein/ligand complex and a solution containing HamptonResearch PACT screen (B4): 25% PEG 1500, 100m MIB pH 7.0. The sample was cryoprotected with 15% ethylene glycol: Crystal tray ID 290655b4, puck ID PWP0-3
|
Resolution 2.10 Å
R-free 0.208
|
|
6O4A
CRYSTAL STRUCTURE OF SMT FUSION PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FROM BURKHOLDERIA PSEUDOMALLEI COMPLEXED WITH SF355
Deposited 2019-02-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain B
13–98（86 aa）
|
Not recorded
|
LLD 2-(pyridin-3-ylcarbonylamino)ethyl (2~{S})-1-(phenylmethyl)sulfonylpiperidine-2-carboxylate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 6.5；289 K；BupsA.00130.a.D21 (CID4597, SMT tag on, Batch 1264062) at 10.37mg/ml (in 25mM Tris, pH8.0, 200mM NaCl, 1% glycerol, 1mM TCEP buffer) was incubated with 2mM SF355 (BSI5667). Crystals were produced by sitting drop vapor diffusion with an equal volume combination of the protein/ligand complex and a solution containing HamptonResearch PACT screen (B4): 25% PEG 1500, 100m MIB pH 7.0. The sample was cryoprotected with 15% ethylene glycol: Crystal tray ID 290655b4, puck ID PWP0-3
|
Resolution 2.10 Å
R-free 0.208
|
|
6O4A
CRYSTAL STRUCTURE OF SMT FUSION PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FROM BURKHOLDERIA PSEUDOMALLEI COMPLEXED WITH SF355
Deposited 2019-02-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain C
13–98（86 aa）
|
Not recorded
|
CA CALCIUM ION × 1
LLD 2-(pyridin-3-ylcarbonylamino)ethyl (2~{S})-1-(phenylmethyl)sulfonylpiperidine-2-carboxylate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 6.5；289 K；BupsA.00130.a.D21 (CID4597, SMT tag on, Batch 1264062) at 10.37mg/ml (in 25mM Tris, pH8.0, 200mM NaCl, 1% glycerol, 1mM TCEP buffer) was incubated with 2mM SF355 (BSI5667). Crystals were produced by sitting drop vapor diffusion with an equal volume combination of the protein/ligand complex and a solution containing HamptonResearch PACT screen (B4): 25% PEG 1500, 100m MIB pH 7.0. The sample was cryoprotected with 15% ethylene glycol: Crystal tray ID 290655b4, puck ID PWP0-3
|
Resolution 2.10 Å
R-free 0.208
|
|
6O4A
CRYSTAL STRUCTURE OF SMT FUSION PEPTIDYL-PROLYL CIS-TRANS ISOMERASE FROM BURKHOLDERIA PSEUDOMALLEI COMPLEXED WITH SF355
Deposited 2019-02-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain D
13–98（86 aa）
|
Not recorded
|
LLD 2-(pyridin-3-ylcarbonylamino)ethyl (2~{S})-1-(phenylmethyl)sulfonylpiperidine-2-carboxylate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 6.5；289 K；BupsA.00130.a.D21 (CID4597, SMT tag on, Batch 1264062) at 10.37mg/ml (in 25mM Tris, pH8.0, 200mM NaCl, 1% glycerol, 1mM TCEP buffer) was incubated with 2mM SF355 (BSI5667). Crystals were produced by sitting drop vapor diffusion with an equal volume combination of the protein/ligand complex and a solution containing HamptonResearch PACT screen (B4): 25% PEG 1500, 100m MIB pH 7.0. The sample was cryoprotected with 15% ethylene glycol: Crystal tray ID 290655b4, puck ID PWP0-3
|
Resolution 2.10 Å
R-free 0.208
|
|
6P81
Structure of DNA polymerase III, beta subunit/ beta sliding clamp from Klebsiella pneumoniae, expressed with an N-terminal His-Smt3 fusion tag, in complex with Griselimycin
Deposited 2019-06-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain A
13–98（86 aa）
Fragment：KlpnA.17987.a.EN11
|
Not recorded
|
CA CALCIUM ION × 1
PG5 1-METHOXY-2-[2-(2-METHOXY-ETHOXY]-ETHANE × 1
ACT ACETATE ION × 1
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 4.5；290 K；Microlytic MCSG-2, condition D4: 30% (V/V) PEG 300, 200mM Calcium acetate, 100mM sodium acetate / acetic acid pH 4.5:
KlpnA.17987.a.EN11.PD383542 at 20.95mg/ml + 2mM griselimycin: tray 309729 D4: cryo: direct: puck ECJ6-1.
|
Resolution 1.75 Å
R-free 0.213
|
|
6Q2S
Cryo-EM structure of RET/GFRa3/ARTN extracellular complex. The 3D refinement was applied with C2 symmetry.
Deposited 2019-08-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 6
PDB declaration: hexameric
|
Chain A
1–98（98 aa）
Chain B
1–98（98 aa）
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 14
CA CALCIUM ION × 8
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.80 Å
|
|
6RPQ
Crystal structure of PhoCDC21-1 intein
Deposited 2019-05-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain A
2–98（97 aa）
|
Mutation：A101T, C112A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7；293 K；tri-ammonium citrate
|
Resolution 2.65 Å
R-free 0.235
|
|
6UKM
STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound MSA-2
Deposited 2019-10-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer；Protein × 2
PDB declaration: dimeric
|
Chain A
2–98（97 aa）
|
Mutation：G230A,R293Q
|
QAD 4-(5,6-dimethoxy-1-benzothiophen-2-yl)-4-oxobutanoic acid × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION；pH 8.5；298 K；25% PEG 6000, 100 mM Tris, 200 mM NaCl, 2 mM DTT
|
Resolution 1.74 Å
R-free 0.192
|
|
6UKU
STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound 3
Deposited 2019-10-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer；Protein × 2
PDB declaration: dimeric
|
Chain A
2–98（97 aa）
|
Mutation：G230A,R293Q
|
QAV 4,4'-[propane-1,3-diylbis(6-methoxy-1-benzothiene-5,2-diyl)]bis(4-oxobutanoic acid) × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION；pH 8.5；298 K；25% PEG 6000, 100 mM Tris, 200 mM NaCl, 2 mM DTT
|
Resolution 1.68 Å
R-free 0.221
|
|
6UKV
STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound 9
Deposited 2019-10-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer；Protein × 2
PDB declaration: dimeric
|
Chain A
2–98（97 aa）
Chain B
2–98（97 aa）
|
Mutation：G230A,R293Q
Mutation：G230A,R293Q
|
QB1 4-[6-(3-{[2-(3-carboxypropanoyl)-6-methoxy-1-benzothiophen-5-yl]oxy}propoxy)-5-methoxy-1-benzothiophen-2-yl]-4-oxobutanoic acid × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION；pH 8.5；298 K；25% PEG 6000, 100 mM Tris, 200 mM NaCl, 2 mM DTT
|
Resolution 1.83 Å
R-free 0.208
|
|
6UKW
STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound 10
Deposited 2019-10-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer；Protein × 2
PDB declaration: dimeric
|
Chain A
2–98（97 aa）
Chain B
2–98（97 aa）
|
Mutation：G230A,R293Q
Mutation：G230A,R293Q
|
QB7 4-[6-(3-{[2-(3-carboxypropanoyl)-4-fluoro-6-methoxy-1-benzothiophen-5-yl]oxy}propoxy)-5-methoxy-1-benzothiophen-2-yl]-4-oxobutanoic acid × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION；pH 8.5；298 K；25% PEG 6000, 100 mM Tris, 200 mM NaCl, 2 mM DTT
|
Resolution 1.97 Å
R-free 0.241
|
|
6UKX
STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound 11
Deposited 2019-10-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer；Protein × 2
PDB declaration: dimeric
|
Chain A
2–98（97 aa）
Chain B
2–98（97 aa）
|
Mutation：G230A,R293Q
Mutation：G230A,R293Q
|
QBA 4,4'-{propane-1,3-diylbis[oxy(5-methoxy-1-benzothiene-6,2-diyl)]}bis(4-oxobutanoic acid) × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION；pH 8.5；298 K；25% PEG 6000, 100 mM Tris, 200 mM NaCl, 2 mM DTT
|
Resolution 1.93 Å
R-free 0.217
|
|
6UKY
STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound 12
Deposited 2019-10-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer；Protein × 2
PDB declaration: dimeric
|
Chain A
2–98（97 aa）
|
Mutation：G230A,R293Q
|
QBD 4-(6-{3-[2-(3-carboxypropanoyl)-6-methoxy-1-benzothiophen-4-yl]propyl}-5-methoxy-1-benzothiophen-2-yl)-4-oxobutanoic acid × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION；pH 8.5；298 K；25% PEG 6000, 100 mM Tris, 200 mM NaCl, 2 mM DTT
|
Resolution 1.95 Å
R-free 0.227
|
|
6UKZ
STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound 6
Deposited 2019-10-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer；Protein × 2
PDB declaration: dimeric
|
Chain A
2–98（97 aa）
Chain B
2–98（97 aa）
|
Mutation：G230A,R293Q
Mutation：G230A,R293Q
|
QBG 4-[5-(2-{[2-(3-carboxypropanoyl)-4-fluoro-6-methoxy-1-benzothiophen-5-yl]oxy}ethoxy)-6-methoxy-1-benzothiophen-2-yl]-4-oxobutanoic acid × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION；pH 8.5；298 K；25% PEG 6000, 100 mM Tris, 200 mM NaCl, 2 mM DTT
|
Resolution 1.52 Å
R-free 0.213
|
|
6UL0
STING C-terminal Domain Complexed with Non-cyclic Dinucleotide Compound 4
Deposited 2019-10-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer；Protein × 2
PDB declaration: dimeric
|
Chain A
2–98（97 aa）
|
Mutation：G230A,R293Q
|
QBJ 4-{5-[(1Z)-3-{[2-(3-carboxypropanoyl)-6-methoxy-1-benzothiophen-5-yl]oxy}prop-1-en-1-yl]-6-methoxy-1-benzothiophen-2-yl}-4-oxobutanoic acid × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION；pH 8.5；298 K；25% PEG 6000, 100 mM Tris, 200 mM NaCl, 2 mM DTT
|
Resolution 1.76 Å
R-free 0.242
|
|
6VEL
Crystal Structure of Human E-cadherin bound by mouse monoclonal antibody 66E8Fab
Deposited 2020-01-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 3
PDB declaration: trimeric
|
Chain C
1–98（98 aa）
|
Not recorded
|
SO4 SULFATE ION × 6
CA CALCIUM ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；290 K；A complex of HosaA.19747.a.KW2, MumuA.20194.a.LG23, and MumuA.20195.a.LH23 was crystallized at 10.4 mg/ml at 14C and mixed 1:1 with 12.5% (w/v) PEG 4000, 20% (v/v) 1,2,6-hexanetriol, 0.1M GlyGly/AMPD pH 8.5, 0.03M of each Lithium sulfate, Sodium sulfate, and Potassium sulfate. Tray 307437a10: puck ckt8-9.
|
Resolution 2.65 Å
R-free 0.236
|
|
6VW2
Cryo-EM structure of human islet amyloid polypeptide (hIAPP, or amylin) fibrils
Deposited 2020-02-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer；Protein × 10
PDB declaration: decameric
|
Chain A
1–97（97 aa）
Chain B
1–97（97 aa）
Chain C
1–97（97 aa）
Chain D
1–97（97 aa）
Chain E
1–97（97 aa）
Chain F
1–97（97 aa）
Chain G
1–97（97 aa）
Chain H
1–97（97 aa）
Chain I
1–97（97 aa）
Chain J
1–97（97 aa）
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å
|
|
7LTO
Nse5-6 complex
Deposited 2021-02-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain B
1–98（98 aa）
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
7O2W
Structure of the C9orf72-SMCR8 complex
Deposited 2021-03-31
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain A
2–96（95 aa）
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.80 Å
|
|
7P47
Structure of the E3 ligase Smc5/Nse2 in complex with Ubc9-SUMO thioester mimetic
Deposited 2021-07-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer；Protein × 5
PDB declaration: pentameric
|
Chain D
1–98（98 aa）
Chain E
1–98（98 aa）
|
Not recorded
|
ZN ZINC ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；311 K；12% PEG8000, 0.2M dimethyl-2-hydroxyethylammoniumpropane sulfonate (NDSB 211), 8% ethylene glycol, 0.1M MES pH 6.5
|
Resolution 3.31 Å
R-free 0.293
|
|
7P7I
Native structure of N-acetylglucosamine kinase from Plesiomonas shigelloides
Deposited 2021-07-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer；Protein × 2
PDB declaration: dimeric
|
Chain AAA
2–96（95 aa）
Chain BBB
2–96（95 aa）
|
Not recorded
|
PEG DI(HYDROXYETHYL)ETHER × 3
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
ZN ZINC ION × 2
PGE TRIETHYLENE GLYCOL × 2
EDO 1,2-ETHANEDIOL × 8
CL CHLORIDE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICROBATCH；291 K；60 mM divalent cations; 0.1 M Tris/bicine pH 8.5; 12.5% each MPD, PEG 1K, PEG 3350.
condition A12 from Morpheus screen (Molecular Dimensions)
|
Resolution 1.70 Å
R-free 0.210
|
|
7P7W
N-acetylglucosamine kinase from Plesiomonas shigelloides compexed with alpha-N-acetylglucosamine and ADP
Deposited 2021-07-20
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer；Protein × 2
PDB declaration: dimeric
|
Chain AAA
2–96（95 aa）
Chain BBB
2–96（95 aa）
|
Not recorded
|
ADP ADENOSINE-5'-DIPHOSPHATE × 2
GOL GLYCEROL × 3
IMD IMIDAZOLE × 4
NDG 2-acetamido-2-deoxy-alpha-D-glucopyranose × 2
ZN ZINC ION × 4
EDO 1,2-ETHANEDIOL × 17
PEG DI(HYDROXYETHYL)ETHER × 1
K POTASSIUM ION × 2
IPA ISOPROPYL ALCOHOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICROBATCH；291 K；120 mM alcohols; ; 0.1 M imidazole/MES pH 6.5; 30% each glycerol and PEG 4K
Condition A3 of Morpheus screen (Molecular dimensions). Crystal was soaked for 60 seconds in cryoprotectant containing 10 mM
ADP
|
Resolution 1.57 Å
R-free 0.211
|
|
7P9L
N-acetylglucosamine kinase from Plesiomonas shigelloides compexed with alpha-N-acetylglucosamine-6-phosphate
Deposited 2021-07-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer；Protein × 2
PDB declaration: dimeric
|
Chain AAA
2–96（95 aa）
Chain BBB
2–96（95 aa）
|
Not recorded
|
EDO 1,2-ETHANEDIOL × 22
PEG DI(HYDROXYETHYL)ETHER × 7
4QY 2-acetamido-2-deoxy-6-O-phosphono-beta-D-glucopyranose × 2
ZN ZINC ION × 4
K POTASSIUM ION × 2
PO4 PHOSPHATE ION × 2
CL CHLORIDE ION × 1
TRS 2-AMINO-2-HYDROXYMETHYL-PROPANE-1,3-DIOL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICROBATCH；291 K；90 mM halogens; 0.1 M Tris/bicine pH 8.5; 30% each PEG 550 MME and PEG 20K,
condition B9 from Morpheus screen (Molecular Dimensions)
|
Resolution 1.75 Å
R-free 0.223
|
|
7P9P
N-acetylglucosamine kinase from Plesiomonas shigelloides compexed with alpha-N-acetylglucosamine and AMP-PNP inhibitor
Deposited 2021-07-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer；Protein × 2
PDB declaration: dimeric
|
Chain AAA
2–96（95 aa）
Chain BBB
2–96（95 aa）
|
Not recorded
|
ZN ZINC ION × 4
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2
PEG DI(HYDROXYETHYL)ETHER × 3
PGE TRIETHYLENE GLYCOL × 2
NDG 2-acetamido-2-deoxy-alpha-D-glucopyranose × 2
EDO 1,2-ETHANEDIOL × 15
K POTASSIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICROBATCH；291 K；60 mM divalent cations; 0.1 M imidazole/MES pH 6.5; 30% each glycerol and PEG 4K. Condition A3 from Morpheus screen (Molecular Dimensions)
|
Resolution 2.11 Å
R-free 0.233
|
|
7P9Y
N-acetylglucosamine kinase from Plesiomonas shigelloides compexed with alpha-N-acetylglucosamine
Deposited 2021-07-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer；Protein × 2
PDB declaration: dimeric
|
Chain AAA
2–96（95 aa）
Chain BBB
2–96（95 aa）
|
Not recorded
|
MPD (4S)-2-METHYL-2,4-PENTANEDIOL × 3
EDO 1,2-ETHANEDIOL × 16
PGE TRIETHYLENE GLYCOL × 1
NDG 2-acetamido-2-deoxy-alpha-D-glucopyranose × 2
ZN ZINC ION × 4
K POTASSIUM ION × 2
CL CHLORIDE ION × 2
PEG DI(HYDROXYETHYL)ETHER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICROBATCH；291 K；90 mM halogens; 0.1 M Na-HEPES/MOPS pH 7.5; 12.5% each MPD, PEG 1K, PEG 3350
Condition B8 of Morpheus screen (Molecular Dimensions)
|
Resolution 1.94 Å
R-free 0.250
|
|
7PA1
Structure of N-acetylglucosamine kinase from Plesiomonas shigelloides in complex with AMP-PNP in the absence of N-acetylglucoseamine substrate
Deposited 2021-07-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer；Protein × 2
PDB declaration: dimeric
|
Chain AAA
2–96（95 aa）
Chain BBB
2–96（95 aa）
|
Not recorded
|
PEG DI(HYDROXYETHYL)ETHER × 2
ANP PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER × 2
ZN ZINC ION × 2
PGE TRIETHYLENE GLYCOL × 4
EDO 1,2-ETHANEDIOL × 9
|
X-RAY DIFFRACTION
X-ray crystallization conditions
MICROBATCH；291 K；0.09M NPS; 0.1 M Tris/bicine pH 8.5; 30% each PEG 550 MME and PEG 20K, condition C9 from Morpheus crystallisation screen (Molecular Dimensions).
|
Resolution 2.20 Å
R-free 0.252
|
|
7SDE
Cryo-EM structure of Nse5/6 heterodimer
Deposited 2021-09-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain B
1–98（98 aa）
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
7ZHS
3D reconstruction of the cylindrical assembly of DnaJA2 delta G/F by imposing D5 symmetry
Deposited 2022-04-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer；Protein × 40
PDB declaration: 40-meric
|
Chain A
3–98（96 aa）
Chain B
3–98（96 aa）
Chain C
3–98（96 aa）
Chain D
3–98（96 aa）
Chain E
3–98（96 aa）
Chain F
3–98（96 aa）
Chain G
3–98（96 aa）
Chain H
3–98（96 aa）
Chain I
3–98（96 aa）
Chain J
3–98（96 aa）
Chain K
3–98（96 aa）
Chain L
3–98（96 aa）
Chain M
3–98（96 aa）
Chain N
3–98（96 aa）
Chain O
3–98（96 aa）
Chain P
3–98（96 aa）
Chain Q
3–98（96 aa）
Chain R
3–98（96 aa）
Chain S
3–98（96 aa）
Chain T
3–98（96 aa）
Chain U
3–98（96 aa）
Chain V
3–98（96 aa）
Chain W
3–98（96 aa）
Chain X
3–98（96 aa）
Chain Y
3–98（96 aa）
Chain Z
3–98（96 aa）
Chain a
3–98（96 aa）
Chain b
3–98（96 aa）
Chain c
3–98（96 aa）
Chain d
3–98（96 aa）
Chain e
3–98（96 aa）
Chain f
3–98（96 aa）
Chain g
3–98（96 aa）
Chain h
3–98（96 aa）
Chain i
3–98（96 aa）
Chain j
3–98（96 aa）
Chain k
3–98（96 aa）
Chain l
3–98（96 aa）
Chain m
3–98（96 aa）
Chain n
3–98（96 aa）
|
Not recorded
|
ZN ZINC ION × 80
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 6.90 Å
|
|
7ZWL
Crystal structure of human STING in complex with 3',3'-c-di-(2'F,2'd<carba>AMP)
Deposited 2022-05-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer；Protein × 3
PDB declaration: trimeric
|
Chain C
2–98（97 aa）
|
Not recorded
|
K43 9-[(1~{R},6~{R},8~{R},9~{S},10~{R},15~{R},17~{R},18~{S})-17-(6-aminopurin-9-yl)-9,18-bis(fluoranyl)-3,12-bis(oxidanyl)-3,12-bis(oxidanylidene)-2,4,11,13-tetraoxa-3$l^{5},12$l^{5}-diphosphatricyclo[13.3.0.0^{6,10}]octadecan-8-yl]purin-6-amine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；291 K；0.2 M Lithium acetate,
20% (w/v) PEG 3350
|
Resolution 2.00 Å
R-free 0.249
|
|
8B7F
Nuclease from C. glutamicum
Deposited 2022-09-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer；Protein × 2
PDB declaration: dimeric
|
Chain A
2–98（97 aa）
Chain B
2–98（97 aa）
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；291 K；10% (w/v) PEG 6K, 30% (v/v) ethanol and 10 mM sodium acetate
|
Resolution 4.60 Å
R-free 0.311
|
|
8DMB
Structure of Desulfovirgula thermocuniculi IsrB (DtIsrB) in complex with omega RNA and target DNA
Deposited 2022-07-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Other combination
Monomer；Protein × 1
PDB declaration: tetrameric
|
Chain P
1–98（98 aa）
|
Mutation：H584L
|
MG MAGNESIUM ION × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å
|
|
8R1F
Monomeric E6AP-E6-p53 ternary complex
Deposited 2023-11-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 3
PDB declaration: trimeric
|
Chain B
1–98（98 aa）
|
Mutation：C80S,C97S,C111S,C140S
|
ZN ZINC ION × 3
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.67 Å
|
|
8R1G
Dimeric ternary structure of E6AP-E6-p53
Deposited 2023-11-01
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 6
PDB declaration: hexameric
|
Chain B
1–98（98 aa）
Chain E
1–98（98 aa）
|
Mutation：C80S,C97S,C111S,C140S
Mutation：C80S,C97S,C111S,C140S
|
ZN ZINC ION × 6
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.99 Å
|
|
8UZH
SUMO fused Trehalose Synthase (TreS) of Mycobacterium tuberculosis
Deposited 2023-11-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer；Protein × 4
PDB declaration: tetrameric
|
Chain A
2–98（97 aa）
Chain B
2–98（97 aa）
|
Not recorded
|
CA CALCIUM ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；289 K；0.8 M Ammonium sulfate, 0.1 M Sodium Citrate pH 5.0
|
Resolution 2.80 Å
R-free 0.290
|
|
8VQH
CryoEM structure of BchN-BchB electron acceptor component protein of DPOR
Deposited 2024-01-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 4
PDB declaration: tetrameric
|
Chain B
1–96（96 aa）
Chain D
1–96（96 aa）
|
Not recorded
|
SF4 IRON/SULFUR CLUSTER × 2
CU COPPER (II) ION × 2
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.70 Å
|
|
8X7V
Structure of human SCMC ternary complex
Deposited 2023-11-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 3
PDB declaration: trimeric
|
Chain C
1–98（98 aa）
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.01 Å
|
|
8X7W
Structure of dimeric human SCMC complex
Deposited 2023-11-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 6
PDB declaration: hexameric
|
Chain C
1–98（98 aa）
Chain F
1–98（98 aa）
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.36 Å
|
|
9E7U
Cryo-EM structure of NOT1:NOT8:PieF
Deposited 2024-11-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 3
PDB declaration: trimeric
|
Chain C
1–95（95 aa）
|
Not recorded
|
MG MAGNESIUM ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.50 Å
|
|
9E7V
Off-pathway Mycobacterium tuberculosis transcription initiation promoter complex (RNA Polymerase with Sigma-A, CarD, and RbpA)
Deposited 2024-11-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 8
PDB declaration: decameric
|
Chain M
1–98（98 aa）
|
Not recorded
|
POP PYROPHOSPHATE 2- × 1
ZN ZINC ION × 2
MG MAGNESIUM ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å
|
|
9E7Y
De Novo Mycobacterium tuberculosis transcription initiation promoter complex with 7-mer RNA and disordered Beta' Lid element (RNA Polymerase with Sigma-A, CarD, and RbpA)
Deposited 2024-11-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 8
PDB declaration: undecameric
|
Chain M
1–98（98 aa）
|
Not recorded
|
POP PYROPHOSPHATE 2- × 1
ZN ZINC ION × 2
MG MAGNESIUM ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.20 Å
|
|
9E84
De Novo Mycobacterium tuberculosis transcription initiation promoter complex with 6-mer RNA and disordered Sigma-A region 4 domain (RNA Polymerase with Sigma-A, CarD, and RbpA)
Deposited 2024-11-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 8
PDB declaration: 11-meric
|
Chain M
1–98（98 aa）
|
Not recorded
|
POP PYROPHOSPHATE 2- × 1
ZN ZINC ION × 2
MG MAGNESIUM ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.60 Å
|
|
9E85
De Novo Mycobacterium tuberculosis transcription initiation promoter complex with 6-mer RNA and closed Beta' clamp (RNA Polymerase with Sigma-A, CarD, and RbpA)
Deposited 2024-11-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 8
PDB declaration: 11-meric
|
Chain M
1–98（98 aa）
|
Not recorded
|
POP PYROPHOSPHATE 2- × 1
ZN ZINC ION × 2
MG MAGNESIUM ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å
|
|
9E86
De Novo Mycobacterium tuberculosis transcription initiation promoter complex with 5-mer RNA and open Beta' clamp (RNA Polymerase with Sigma-A, CarD, and RbpA)
Deposited 2024-11-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 8
PDB declaration: 11-meric
|
Chain M
1–98（98 aa）
|
Not recorded
|
POP PYROPHOSPHATE 2- × 1
ZN ZINC ION × 2
MG MAGNESIUM ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.80 Å
|
|
9E87
De Novo Mycobacterium tuberculosis transcription initiation pre-RPO promoter complex with open Beta' clamp (RNA Polymerase with Sigma-A, CarD, and RbpA)
Deposited 2024-11-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 8
PDB declaration: decameric
|
Chain M
1–98（98 aa）
|
Not recorded
|
ZN ZINC ION × 2
MG MAGNESIUM ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.60 Å
|
|
9E88
De novo backtracked transcription elongation complex of Mycobacterium tuberculosis RNA polymerase on a linear DNA fragment (TEC-Backtracked)
Deposited 2024-11-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 6
PDB declaration: nonameric
|
Chain M
1–98（98 aa）
|
Not recorded
|
ZN ZINC ION × 2
MG MAGNESIUM ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.40 Å
|
|
9G8I
Sumo-Darpin-A10-complex
Deposited 2024-07-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain C
21–95（75 aa）
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；293 K；Bis-Tris pH 6.5, 23% (v/v) PEG 3350
|
Resolution 2.51 Å
R-free 0.301
|
|
9G8I
Sumo-Darpin-A10-complex
Deposited 2024-07-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain D
21–95（75 aa）
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；293 K；Bis-Tris pH 6.5, 23% (v/v) PEG 3350
|
Resolution 2.51 Å
R-free 0.301
|
|
9GAU
Sumo-Darpin-C10-complex
Deposited 2024-07-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain B
21–96（76 aa）
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 6.5；293 K；0.1M Bis-Tris. 16% (v/v)PEG 3350
|
Resolution 2.64 Å
R-free 0.288
|
|
9HDO
The Human LINE-1 ORF2p target-primed reverse transcription complex
Deposited 2024-11-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: heptameric
|
Chain A
2–98（97 aa）
|
Not recorded
|
MG MAGNESIUM ION × 1
ZN ZINC ION × 1
D3T 2',3'-DIDEOXY-THYMIDINE-5'-TRIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.30 Å
|
|
9HDP
The Human LINE-1 ORF2p target-primed reverse transcription complex with the fingers domain in a closed conformation
Deposited 2024-11-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: heptameric
|
Chain A
2–98（97 aa）
|
Not recorded
|
MG MAGNESIUM ION × 1
ZN ZINC ION × 1
D3T 2',3'-DIDEOXY-THYMIDINE-5'-TRIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.50 Å
|
|
9HDQ
The Human LINE-1 ORF2p target-primed reverse transcription complex with the fingers domain in an open conformation
Deposited 2024-11-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: heptameric
|
Chain A
2–98（97 aa）
|
Not recorded
|
ZN ZINC ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.45 Å
|
|
9HDR
Human LINE-1 ORF2p target-primed reverse transcription complex with EN domain resolved
Deposited 2024-11-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: heptameric
|
Chain A
2–98（97 aa）
|
Not recorded
|
MG MAGNESIUM ION × 1
ZN ZINC ION × 1
D3T 2',3'-DIDEOXY-THYMIDINE-5'-TRIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å
|
|
9HX5
Apo structure of SRSF6 RRM2 WT
Deposited 2025-01-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain A
13–98（86 aa）
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 8.5；277 K；0.1 M Bis-Tris propane pH 8.5, 0.2 M Sodium sulfate, 20 % PEG 3350, 10 % Ethylene glycol
|
Resolution 2.10 Å
R-free 0.258
|
|
9HX7
Structure of SRSF6 RRM2 WT with "GGA"-RNA
Deposited 2025-01-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: dimeric
|
Chain A
13–98（86 aa）
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP；pH 7；277 K；0.1 M HEPES pH 7.0, 0.1 M NH4SO4, 0.1 M Na-Form, 25 % Smear Broad
|
Resolution 2.30 Å
R-free 0.250
|
|
9HX8
Apo structure of SRSF6 RRM2 W123A
Deposited 2025-01-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain A
13–98（86 aa）
|
Mutation：W123A
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 8；277 K；0.1 M Na-Citrate, 20 % PEG 3350
|
Resolution 2.00 Å
R-free 0.259
|
|
9IIS
GDP-fucose pyrophosphorylase part of FKP with a SUMO tag
Deposited 2024-06-21
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: monomeric
|
Chain A
1–98（98 aa）
|
Not recorded
|
EPE 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID × 1
ACT ACETATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；pH 7.5；295 K；PEG 3350, ammonium acetate, HEPES
|
Resolution 2.36 Å
R-free 0.254
|
|
9KPZ
Structure of TolQRA complex at pH 5.4 from E.coli
Deposited 2024-11-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 12
PDB declaration: dodecameric
|
Chain H
3–99（97 aa）
Chain I
3–99（97 aa）
Chain J
3–99（97 aa）
Chain K
3–99（97 aa）
Chain L
3–99（97 aa）
|
Not recorded
|
3PE 1,2-Distearoyl-sn-glycerophosphoethanolamine × 7
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 5.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.18 Å
|
|
9KQ0
Structure of TolQRA complex at pH 8.0 from E.coli
Deposited 2024-11-24
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 12
PDB declaration: dodecameric
|
Chain H
3–99（97 aa）
Chain I
3–99（97 aa）
Chain J
3–99（97 aa）
Chain K
3–99（97 aa）
Chain L
3–99（97 aa）
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 8
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.60 Å
|
|
9MB6
Cryo-EM structure of wild-type SaCas9-guide RNA-mismatched target DNA complex
Deposited 2025-03-15
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: tetrameric
|
Chain A
3–98（96 aa）
|
Not recorded
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.6
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.01 Å
|
|
9MB7
Cryo-EM structure of eSaCas9-NNG-guide RNA-mismatched target DNA complex
Deposited 2025-03-15
|
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
|
Assembly 1
Insufficient information
Monomer；Protein × 1
PDB declaration: tetrameric
|
Chain A
3–98（96 aa）
|
Not recorded
|
MG MAGNESIUM ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.6
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.88 Å
|
|
9OIK
Structure of S. Typhimurium 14028 Gifsy-1 prophage HepS bound to bacteriophage lambda J Tail Tip
Deposited 2025-05-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 8
PDB declaration: octameric
|
Chain C
1–98（98 aa）
Chain D
1–98（98 aa）
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP；291 K；0.2 M Sodium Acetate, 16% PEG 4000, 0.1 M Tris pH 8.5
|
Resolution 1.86 Å
R-free 0.209
|
|
9OPR
TMPRSS2 S441A in complex with the H1H7 Fab and anti-kappa light chain nanobody
Deposited 2025-05-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 4
PDB declaration: tetrameric
|
Chain A
1–94（94 aa）
|
Mutation：S441A
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
9SMX
CM1-activated gTuRC in complex with nascent alpha-E254D mutant microtubules
Deposited 2025-09-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 73
PDB declaration: 73-meric
|
Chain AC
2–99（98 aa）
Chain CC
2–99（98 aa）
Chain Cc
2–99（98 aa）
Chain EC
2–99（98 aa）
Chain Ec
2–99（98 aa）
Chain GC
2–99（98 aa）
Chain Gc
2–99（98 aa）
Chain MC
2–99（98 aa）
Chain Mc
2–99（98 aa）
|
Not recorded
|
GTP GUANOSINE-5'-TRIPHOSPHATE × 11
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 6.9
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.67 Å
|
|
9SYR
Human quaternary complex of a translating 80S ribosome, NAC, MetAP1 and NatD
Deposited 2025-10-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 80
PDB declaration: 86-meric
|
Chain Nd
4–98（95 aa）
|
Not recorded
|
ZN ZINC ION × 10
COA COENZYME A × 1
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE-PROPANE
|
Resolution 3.55 Å
|
|
9UT1
The helicase-primase complex from HHV1 bound with ssDNA and amenamevir
Deposited 2025-05-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 3
PDB declaration: tetrameric
|
Chain B
3–98（96 aa）
Chain C
3–98（96 aa）
|
Mutation：R64T/R71E
Mutation：R64T/R71E
|
A1BXD Amenamevir × 1
ZN ZINC ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.14 Å
|
|
9UT4
The primase module of the helicase-primase complex from HHV1 bound with ssDNA and amenamevir
Deposited 2025-05-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain B
3–98（96 aa）
Chain C
3–98（96 aa）
|
Mutation：R64T/R71E
Mutation：R64T/R71E
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 2.91 Å
|
|
9UT5
The helicase-primase complex from HHV1 bound with ssDNA and pritelivir
Deposited 2025-05-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 3
PDB declaration: tetrameric
|
Chain B
3–98（96 aa）
Chain C
3–98（96 aa）
|
Mutation：R64T/R71E
Mutation：R64T/R71E
|
A1BXB Pritelivir × 1
ZN ZINC ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.32 Å
|
|
9UT6
The helicase module of the helicase-primase complex from HHV1 bound with ssDNA and pritelivir
Deposited 2025-05-02
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 2
PDB declaration: trimeric
|
Chain B
3–98（96 aa）
|
Mutation：R64T/R71E
|
A1BXB Pritelivir × 1
ZN ZINC ION × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.12 Å
|
|
9UT7
The Primase module of the helicase-primase complex from HHV1 bound with ssDNA and pritelivir
Deposited 2025-05-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer；Protein × 2
PDB declaration: dimeric
|
Chain B
3–98（96 aa）
Chain C
3–98（96 aa）
|
Mutation：R64T/R71E
Mutation：R64T/R71E
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.08 Å
|
|
9Z3K
SARS-CoV-2 S2 trimer stabilized in the early fusion intermediate conformation by circular permutation and clamping by gp41 (E-FICs-v1)
Deposited 2025-11-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Homooligomer；Protein × 3
PDB declaration: trimeric
|
Chain A
1–94（94 aa）
Chain B
1–94（94 aa）
Chain C
1–94（94 aa）
|
Not recorded
|
NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 18
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.30 Å
|
